Deals
Hambro Perks SPAC Eyes Merger With Biotech Istesso, Sky Says
This article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
Hambro Perks Acquisition Co., the first blank-check firm to list in London after a rule change, is discussing a possible merger with closely held pharmaceutical company Istesso Ltd., Sky News reported, citing sources it didn’t identify.